Buradasınız

Primer hiperparatiroidizmde cerrahi tedavi ve sonuçları

Surgıcal treatment and results of prımary hyperparathyroıdısm

Journal Name:

Publication Year:

Abstract (2. Language): 
In this study we aimed to evaluate the results of surgical treatment of 11 patients who were treated for primary hyperparathyroidism and followed up in the outpatient clinic of our hospital between 1996-2002. All the patients were women with a mean age of 52.7(between 40-73 years).The mean follow-up time was 9.2 months(between 3-16 months).The mean period of time since onset of symptoms till diagnosis was 22.4 months(between 4-48 months). All the patients had osteodystrophic changes.There were not any asympto¬matic patient in our study group. Preoperative localisation studies included ultrasonography(USG) ,magnetic resonance imaging (MRI) and Tc -sesta MIBI 99m scintigraphy (Sg). One staged initial operation was enough in 9 patients,whereas a second operation was needed in 2 patients. In conclusion, primary hyperparathy-roidism is still an underestimated disease in Turkey and patients are rarely asymptomatic due to delayed diagnosis. According to the western literature however, most of the patients are reported to be asymptomatic. Patients do feel better but they are rarely free of symptoms after surgery. Surgery should be offered even to the asymptomatic patients, because the treatment of possible future complications might be extremely dif¬ficult. Although these outcomes, surgery still remains as the only treatment modality for primary hyper-parathyroidism.
Abstract (Original Language): 
Bu çalışmada primer hiperparatiroidizm nedeni ile 1996-2002 yılları arasında cerrahi servisimizde ameliyat edilen 11 hastanın tedavi sonuçlarını literatür eşliğinde değerlendirdik. Olguların tamamı kadın olup, ortalama yaş 52.7(40-73 yaş arası değişen şekilde)'idi. Ortalama takip süresi 9.2 aydır (3-16 ay arası değişen şekilde). Semptomların ortaya çıkışı ile tanı arasında geçen süre ortalama 22.4 aydır(4-48 ay arası değişen şekilde). Tüm hastalarda osteodistrofik değişiklikler mevcuttu.Asemptomatik hastamız yoktu. Ameliyat öncesi lokalizasyon çalışmaları arasında ultrasonografi(USG), manyetik rezonans görüntüleme (MRI) ve Tc-sesta MIBI 99m sintigrafisine (Sg) yer verildi.Onbir hastamızın dokuzuna bir cerrahi girişim yeterli olurken,bir hastamızda ameliyat sonrası patolojinin lenf nodülü ile uyumlu gelmesi diğer bir hastamız¬da ise piyesin normal ektopik tiroid dokusu olduğu şeklinde rapor edilmesi üzerine bu iki hastaya mükerrer cerrahi girişim uygulanması gerekmiştir. Sonuç olarak ülkemizde primer hiperparatiroidizm henüz yeterince dikkat çekmeyen bir hastalık olup hastaların tanısı nadiren asemptomatik evrede konabilmektedir. Buna karşın batı kaynaklı literatürlerde opere edilen hastaların büyük çoğunluğu asemptomatiktir. Asemptomatik hastalarda oluşabilecek komplikasyonlarla baş edebilmek güç olduğu için bu tür hastalara dahi cerrahi öner¬ilmelidir. Hastalar ameliyat sonrası kendilerini daha iyi hissetmekle birlikte ,semptomlarından tamamen arın¬maları nadirdir. Tüm bunlara rağmen hiperparatiroidizmde cerrahi vazgeçilmez tedavi modalitesidir.
10-16

REFERENCES

References: 

1- Clark OH.Surgical treatment of primary hyper-parathyroidism.Adv Endocrinol Metab 1995;6:1.
2- Heath H,Hodgson SF,Kenedy MA.Primary hyper-parathyroidism.Incidence ,morbidity and potential economic impact in a community.N Engl J Med 1992;302:376.
3- Potts JT Jr.Management of asymptomatic hyper-parathyroidism: a report on the NIH consensus devel¬opment conference .Trends Endocrinol Metab 1992;10:376.
4- Fischer JA."Asymptomatic" and symptomatic pri¬mary hyperparathyroidism.Clin Investig 1993;71:505.
5- Breslau NA,Pak
CY
C .Asymptomatic primary hyperparathyroidism."Disorders of bone and mineral metabolism" Ed.Coe FC,Favus MF,Raven Press,New York 1992;523.
6- Aparwal G,Mishra SK,Kar DK,Singh AK,Arya V,Gupto SK,Mithal A.Recovery
patter
n of patients with osteitis fibrosa cystica in primary hyperparathy-roidism after succesful parathyroidectomy.Surgery 2002;132(6):1075-85.
7- Sofferman RA,Standage J,Tang ME.Minimal access parathyroid surgery using intraoperative parathyroid hormone assay.Laryngoscope 1998;108(10):1497-503.
8- Elanj DM,Remaley AT,Simonds WF,Skarulis NC,Libutti SK,Barkett DL,Venzon DJ,Marx SJ,Alexander HR.Utility of rapid intraoperative parathyroid hormone assay to predict severe postop¬erative hypocalcemia after reoperation for hyper-parathyroidism.Surgery 2002;132(6):1028 -34.
9- Graham EM,Freedman LJ,Forouzan I.Intrauterine growth retardation in a woman with primary hyper-parathyroidism.J Reprod Med 1998;43(5):451-4.
10- Von Poblotzki M,Strauss A,Shulze A,Hepp H.Primary hyperparathyroidism with persistent hypercalcemia in pregnancy.Gynakol Geburtshilfliche Rundsch 2003;43(1):36-8.
11- Clark OH,Duh Q-Y.Primary hyperparathy-roidism.A surgical perspective .Endocrinol Metab Clin North Am 1989;18:701.
12- Norman J,Chedda H.Minimally invasive parathy-roidectomy facilitated by intraoperative nuclear map-ping.Surgery 1997;122:998.
13- Miccoli P,Bendinelli Ci Vignali E,et al.Endoscopic parathyroidectomy.Report of an initial experience
Süleyman Demirel Üniversitesi Tıp Fakültesi Dergisi 2001:8-( 4 ) / 1 0 - 1 6
16
Kocakuşak,
Prime
r hiperparatiroidizm
.Surgery 1998;124:1077.
14- Procopio M,Magro G,Cesario F,Piovesan A,Pia A,Molineri N,Boretta G.The oral glucose tolerance test reveals a high frequency of both impaired glucose tolerance and undiagnosed Type 2 diabetes mellitus in primary hyperparathyroidism.Diabet Med 2002;19(11):958-61.
15- Hales KF,Rosenberg RJ,Spencer RP.Coexistent parathyroid adenomas and Hurthle cell tumors:failure of full detection by substraction method.Clin Nucl Med 1998;23(4):205-7.
16- Kondo Y,Nagai H,Kasahara K,Kanazawa K.Primary hyperparathyroidism and acute pancreati¬tis during pregnancy.Report of a case and a review of the English and Japanese literature.Int J Pancreatol 1998;24(1):43-7.
17- Royal RE,Delpassand ES,Shapiro SE,Fritsche HA Jr,Vassilopoulou -Sellin R,Sherman SI,Gagel RF,Evans DB,Lete JE.Improving the yield of preoper-ative parathyroid localization:Technetium 99m-ses-tamibi imaging after thyroid suppression.Surgery 2002;132(6):968-75.
18- Kakuta T,Suzuki Y,Taolak F,Vemura K,Tanaka R,Tanaka S,Kuboto M,Sakai H,Kurokawa K,Saito A.Prognosis of parathyroid function after minimally invasive radioguided parathyroidectomy (MIRP) and percutaneous ethanol injection therapy for primary hyperparathyroidism.Biomed Pharmacother 2002;56 Suppl 1:41-47.
19- Agarwal SK,Schrock E,Kester MB,Burus AI,Heffes CS,Ried T.Comparative genomic hybridization analysis of human parathyroid tumors.Cancer Genet Cytogenet 1998;106(1):30-6.
20- Biurneroth G,Juhlin C,Gudmundssan S.Major his-tocompatilibity complex class II expression and parathyroid autoantibodies in primary hyperparathy-roidism.Surgery 1998;124(3):503-9.
21- Klieger P,O'mara R.A case of active sarcoid mim¬icking a mediastinal parathyroid adenoma on Tc -99m sestamibi imaging.Clin Nucl Med 1998;23(8):534-5.
22- Lane MJ,Desser TS,Weigel RJ,Jeffrey RB.Use of color and power Doppler sonography to identify feed¬ing arteries associated with parathyroid adenomas.AJR Am J Roentgenol 1998;171(3):819-
23.
23- Marcocci C,Mazzeo S,Bruno-Bossio G,Picone A.Preoperative localization of suspicious parathyroid adenomas by assay of parathyroid hormone in needle aspirates.Euro J Endocrinol 1998,139(1):72-7.
24- Meekin GK.Intraoperative use of methylene blue localizes parathyroid adenoma .Laryngoscope 1998;108(5):772-3.
25- Yeung GH,Ng JW.The technique of endoscopic exploration for parathyroid adenoma of the neck.Aust N Z J Surg 1998;68(2)147-50.
26- Shiguro K,Ohgi S.Minimally invasive parathy-roidectomy under local anesthesia.Biomed Pharmacother 2002;56 Suppl 1:31-33.
27- Naccarato AG,Marcocci C,Miccoli P.BC 1-2,p53 and MIB -1 expression in normal and neoplastic parathyroid tissue.J Endocrinol Invest 1998;21(3):136-41.
28- Chin KW,Sercarz JA,Wang MB.Spontaneous cer¬vical hemorrhage with near complete airway obstruc-tion.Head Neck 1998;20(4):350-3.
29- Gillis D,Hirsch HJ,Landau H.Parathyroid adeno¬ma after radiation in an 8-year old boy.J Pediatr 1998;132(5):892-3.

Thank you for copying data from http://www.arastirmax.com